Skip to main content

Tourmaline Bio, Inc.

TRMLDelisted Oct 28, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827506

Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Tourmaline Bio, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of TRML: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders51159+9
Shares29.2M3.18K28.9M−269.5K (−0.9%)
Value$286.9M$31.0K$130.4M−$156.4M (−54.5%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Tourmaline Bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to TRML in Q2 2022
InstitutionSharesValue% of portfolio
Bank of Montreal22,442$203.0K0.00%
Dimensional Fund Advisors LP18,277$82.0K0.00%
State Board of Administration of Florida Retirement System14,260$64.0K0.00%
MetLife Investment Management13,923$62.8K0.00%
Virtu Financial LLC12,399$56.0K0.00%
BIT Capital GmbH7,467$55.5K0.01%
Values First Advisors, Inc.11,677$53.0K0.04%
Manufacturers Life Insurance Company, The10,122$45.6K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)1,778$8.00K0.00%
Metropolitan Life Insurance Co1,616$7.29K0.00%
UBS Group AG825$4.00K0.00%
Credit Suisse AG22$00.00%
Rockefeller Capital Management L.P.67$00.00%

Sold out (4)

Institutions that held Tourmaline Bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of TRML in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Nicholas Investment Partners, LP22,500$221.0K
Susquehanna International Group, LLP17,214$169.0K
State of Wisconsin Investment Board11,500$113.0K
Prospera Financial Services Inc5,055$50.0K

Not filed for Q2 2022 yet (1)

Institutions that held Tourmaline Bio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TRML in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Amalgamated Financial Corp.3,184$31.0K